Does Vitamin K Increase INR or Decrease It?

Vitamin K decreases INR. The international normalized ratio (INR) measures how long your blood takes to clot, and higher numbers mean slower clotting. Because vitamin K is essential for producing several of the proteins your body uses to form clots, more vitamin K in your system pushes clotting times down and lowers your INR. This relationship is central to how warfarin and similar blood thinners work, and understanding it matters for anyone managing anticoagulation therapy, adjusting their diet, or dealing with a dangerously high INR reading.

How Vitamin K Controls Clotting

Your liver needs vitamin K to finish building several clotting proteins, including factors II (prothrombin), VII, IX, and X. Without vitamin K, the liver produces incomplete versions of these proteins that cannot participate in clot formation. Early research on rat liver tissue demonstrated that vitamin K is required to convert a precursor protein into functional Factor VII, and that this step is separate from general protein production in the cell.¹ When vitamin K is plentiful, the liver churns out fully functional clotting factors, blood clots efficiently, and INR stays low. When vitamin K is scarce, clotting slows down and INR rises.

Warfarin exploits this dependency. It blocks an enzyme called vitamin K epoxide reductase, which recycles vitamin K so it can be used again. By interrupting that recycling, warfarin effectively starves the liver of usable vitamin K, slowing clotting factor production and raising INR into a therapeutic range. This is why vitamin K and warfarin are direct opponents: vitamin K pushes INR down, warfarin pushes it up, and the balance between the two determines where a patient’s INR lands on any given day.

Using Vitamin K to Lower a Dangerously High INR

When someone on warfarin has an INR that climbs too high, they face an increased risk of serious bleeding. Physicians can simply withhold warfarin and wait, but giving vitamin K brings the INR down faster. A dose of about 1 to 2.5 mg of oral vitamin K can reduce an INR in the range of 5 to 9 down to a safer level within 24 to 48 hours, and for readings above 10, a dose around 5 mg is often used.² Evidence from randomized controlled trials supports oral vitamin K as an effective option, and it works at least as well as a subcutaneous injection when you compare INR values a day later.³

There is an important nuance, though: while vitamin K lowers a high INR faster than just stopping warfarin, research has not clearly proven that this faster correction actually reduces the rate of major bleeding events.² That sounds counterintuitive, because a lower INR should mean less bleeding risk. But in clinical reality, the bleeding events that prompted the high INR reading may have already occurred or may be driven by other factors. The decision to give vitamin K versus just holding warfarin often depends on how high the INR is, whether the patient is actively bleeding, and how urgently they need to return to therapeutic range.

Oral Versus Intravenous Vitamin K

If you need the INR to drop within hours rather than overnight, intravenous vitamin K works faster. In a controlled study comparing oral and IV routes in patients with baseline INR between 6 and 10, nearly half of the IV group had reached therapeutic INR by 6 hours, while none of the oral group had. By 12 hours, two-thirds of the IV group were in range versus about a third of the oral group. But by 24 hours, both groups had arrived at nearly the same INR values.⁴ So the IV route buys you speed, not a better final result. For most non-emergency situations, oral vitamin K is the preferred choice because it is simpler, avoids the rare risk of an allergic reaction associated with IV administration, and still gets the job done within a day.

Getting the dose right also matters. Research comparing ultra-low doses to standard low doses in warfarin patients found that both brought the INR down by a similar amount at 12 hours, with no rebound elevation or excessive correction at 36 hours.⁵ The goal is to nudge the INR back into the safe range without overshooting and making the blood clot too aggressively, which could trigger a stroke or other clotting event in someone who is on warfarin for a reason.

Why Dietary Vitamin K Swings Your INR

If you take warfarin, your doctor has probably told you to keep your vitamin K intake consistent. The reason is straightforward: warfarin’s dose is calibrated to oppose a certain amount of vitamin K activity. If you suddenly eat a large serving of leafy greens, liver, or other vitamin K-rich food, you flood the system with more vitamin K than the warfarin dose can counteract, and your INR drops. Skip those foods for a few days, and the warfarin wins the tug-of-war, pushing your INR higher than expected.

This is not a small effect. A study tracking warfarin patients found a strong inverse relationship between changes in dietary vitamin K intake and INR fluctuations. After adjusting for other variables, a weekly change of roughly 714 micrograms of dietary vitamin K was enough to shift the weekly INR by a full unit.⁶ To put that in perspective, a single cup of cooked kale can contain over 1,000 micrograms of vitamin K. You do not need to avoid vitamin K-rich foods entirely, but dramatic swings from week to week can send your INR on a rollercoaster. Dietary and supplemental vitamin K intake is one of the most controllable contributors to the variability patients experience with warfarin.⁷

The practical advice is not to eliminate vitamin K from your diet but to eat roughly the same amount each week. If you love spinach, eat it regularly rather than bingeing one week and skipping it the next. Your warfarin dose is set around your usual habits, and consistency keeps INR where it should be.

Supplementing Vitamin K to Stabilize INR

This is one of the more counterintuitive ideas in anticoagulation management: giving a small daily dose of vitamin K alongside warfarin to keep INR steadier. The logic is that if dietary vitamin K is the variable causing INR to bounce around, adding a consistent daily supplement removes that variability. It is like setting a floor for your vitamin K levels so that day-to-day diet changes matter less.

A small observational study found that after patients with unstable INRs were given supplemental vitamin K, their INR fluctuations diminished in nearly all cases. The number of INR readings within the target range jumped from about 32% to 57%.⁸ A case report described adding 180 micrograms per day of vitamin K to a patient’s warfarin regimen, with the INR reaching and maintaining therapeutic range for two consecutive months afterward.⁹

But a larger randomized trial of 150 micrograms per day of vitamin K versus placebo in warfarin patients told a more complicated story. The overall time in therapeutic range did not significantly differ between the vitamin K and placebo groups. However, the number of extreme INR excursions, where readings shot below 1.5 or above 4.5, dropped significantly in the vitamin K group. The researchers also noted that both groups showed improved INR control compared with before the study, which they attributed to the more attentive monitoring that came with participating in a trial.¹⁰ The upshot: daily low-dose vitamin K seems to protect against wild INR swings, but it may not improve overall time in range any better than simply paying closer attention to warfarin management.

Antibiotics, Gut Bacteria, and Surprise INR Spikes

Your gut bacteria produce a meaningful amount of vitamin K on their own. The human intestinal tract is estimated to contribute roughly 10 to 50% of the body’s vitamin K supply, primarily through bacteria like Prevotella and Eubacterium that synthesize a form called vitamin K2 (menaquinone).¹¹ This means anything that disrupts your gut flora can indirectly affect your INR.

Antibiotics are the classic culprit. When you take a broad-spectrum antibiotic, it can wipe out vitamin K-producing bacteria, cutting off that internal supply. With less vitamin K available, warfarin’s effect is amplified, and INR can climb unexpectedly. A review of the evidence confirmed that combining antibiotics with a vitamin K antagonist like warfarin can cause INR to rise, increasing bleeding risk.¹² If you are on warfarin and your doctor prescribes antibiotics, extra INR monitoring during and after the course is standard practice for this reason.

Other medications that reduce fat absorption can also interfere. Orlistat, a weight-loss drug that blocks fat digestion in the gut, may reduce absorption of fat-soluble vitamins including vitamin K. Case reports have documented that starting orlistat led to a higher warfarin effect, meaning INR crept up because less vitamin K was getting into the bloodstream.¹³ The mechanism is twofold: the drug itself blocks vitamin K absorption, and people taking it tend to shift toward a lower-fat diet that naturally contains less vitamin K.

Vitamin K1 Versus K2 and the INR

Most of the clinical guidance around INR management focuses on vitamin K1 (phylloquinone), the form abundant in green vegetables and the form used in reversal doses. Vitamin K2 (menaquinone), found in fermented foods, animal products, and synthesized by gut bacteria, gets less attention in anticoagulation discussions, but it does affect INR. A study modeling the effect of vitamin K2 on warfarin activity during catheter ablation procedures found that doses above 20 mg caused a mild, dose-dependent decrease in INR, along with a delayed rebound in INR elevation after warfarin was restarted.¹⁴

For most warfarin patients, K2 from ordinary dietary sources like cheese or natto is not consumed in high enough doses to cause dramatic INR changes. But if you are taking a K2 supplement for bone health or other reasons while on warfarin, it is worth discussing with your doctor. The effect is real and directionally the same as K1: more vitamin K2 means lower INR, though the potency and speed differ.

Genetics and How Much Vitamin K Your Body Needs

Not everyone responds to warfarin and vitamin K identically, and a big part of the reason is genetic. Two genes in particular, CYP2C9 and VKORC1, account for roughly 30 to 50% of the variability in warfarin dosing between patients.¹⁵ CYP2C9 affects how quickly the liver breaks down warfarin, while VKORC1 encodes the very enzyme that warfarin targets. Variants in VKORC1 can make a person either unusually sensitive to warfarin, needing much lower doses, or unusually resistant, requiring higher doses to achieve the same INR.¹⁶

These genetic differences are not distributed evenly across populations. The frequency of sensitivity and resistance variants differs among ethnic and ancestral groups, which is one reason warfarin dosing can vary so much from one person to another. In rare cases, novel VKORC1 mutations can make a patient’s warfarin needs so unusual that a standard fixed-dose approach would be inadequate for maintaining a safe INR.¹⁷ Pharmacogenomic testing before starting warfarin is available and can help guide initial dosing, though its adoption varies by institution.

What this means for the vitamin K side of the equation: a person who is genetically warfarin-sensitive already has less VKORC1 activity, so even modest increases in dietary vitamin K can cause a larger INR swing than expected. Conversely, someone who is genetically warfarin-resistant has a more robust vitamin K recycling system and may tolerate dietary fluctuations with less INR variability. Knowing your genetic profile does not eliminate the need for regular INR monitoring, but it helps explain why two people eating identical diets can have very different INR responses.

Superwarfarin Poisoning and Prolonged Vitamin K Treatment

Superwarfarins are a class of long-acting anticoagulant rodenticides, most commonly brodifacoum, that are far more potent and persistent than warfarin itself. They work through the same mechanism, blocking vitamin K recycling, but they bind much more tightly and have extremely long half-lives in the body. Accidental or intentional ingestion produces a dangerously elevated INR that can take months to normalize.

Treatment relies on vitamin K, but in doses and durations that would be startling in a normal warfarin-reversal scenario. Patients with active bleeding from superwarfarin poisoning may receive clotting factor concentrates or fresh frozen plasma for immediate correction, followed by high-dose vitamin K multiple times per day for weeks to months.¹⁸ Two reported cases of intentional brodifacoum poisoning required 100 mg of oral vitamin K daily, one patient for three months and the other for six months, guided by brodifacoum elimination half-lives of 15 and 33 days respectively.¹⁹ Compare that to the 1 to 5 mg single doses used for routine warfarin over-anticoagulation, and you get a sense of how stubborn these compounds are. If vitamin K is stopped too early, the INR rebounds as the stored rodenticide continues blocking vitamin K recycling.

Vitamin K Deficiency in Newborns

Newborns are uniquely vulnerable to vitamin K deficiency. Vitamin K crosses the placenta poorly, breast milk contains relatively little of it, and a newborn’s gut has not yet been colonized by the bacteria that produce vitamin K2. Without intervention, this combination can lead to vitamin K deficiency bleeding, a condition classified by when it appears: within the first 24 hours of life, within the first week, or between two weeks and six months of age.²⁰ The late-onset form is particularly dangerous because it can involve intracranial hemorrhage.

This is why hospitals routinely give newborns a vitamin K injection shortly after birth. The practice has been standard for decades and has dramatically reduced the incidence of vitamin K deficiency bleeding. The INR connection is the same as in adults: without enough vitamin K, the infant cannot produce functional clotting factors, clotting times lengthen, and the equivalent of an elevated INR results. A single injection provides enough vitamin K to cover the gap until the baby’s diet and gut bacteria can maintain adequate levels on their own. Parents who decline the injection should be aware that exclusively breastfed infants are at the highest risk, since formula is typically fortified with vitamin K.